Position
Chief Operating Officer
Company
Verastem Oncology
NeedhamBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
Verastem Oncology announced the appointment of Matthew E. Ros as chief operating officer. In this role, Mr Ros will report to Dan Paterson, president and chief executive officer, to prepare for a mid-2025 product launch and the transition into a commercial-stage company, while continuing to advance clinical programs and partnerships to address cancers driven by the RAS/MAPK-pathway.
Quick answer
Verastem Oncology Appoints Matthew E. Ros as Chief Operating Officer (January 15, 2025). Verastem Oncology is based in Needham, Massachusetts, United States.
- Who is the new Chief Operating Officer at Verastem Oncology?
- Verastem Oncology named Matthew E. Ros Chief Operating Officer, announced January 15, 2025.
- What did Verastem Oncology announce on January 15, 2025?
- Verastem Oncology announced the appointment of Matthew E. Ros as chief operating officer. In this role, Mr Ros will report to Dan Paterson, president and chief executive officer, to prepare for a mid-2025 product launch and the transition into a commercial-stage company, while continuing to advance clinical programs and partnerships to address cancers driven by the RAS/MAPK-pathway.
- What does Verastem Oncology do?
- Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK...
- Where is Verastem Oncology based?
- Verastem Oncology is based in Needham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Crinetics Pharmaceuticals (February 26, 2025), Oragenics (January 17, 2025), Arcus Biosciences (January 21, 2025) and Nurix Therapeutics (January 22, 2025) also announced leadership changes within 45 days of Verastem Oncology.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Oragenics Appoints Janet Huffman as Interim Chief Executive Officer (January 17, 2025)
- Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer (January 21, 2025)
- Nurix Therapeutics appoints John Northcott as Chief Commercial Officer (January 22, 2025)
- Centessa Pharmaceuticals plc Appoints Stephen Kanes MD PhD as Chief Medical Officer (January 8, 2025)
- Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer (January 7, 2025)
Who to call at Verastem Oncology, and when
A new leader at Verastem Oncology brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Verastem Oncology raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Verastem Oncology, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Verastem Oncology. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Verastem Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Verastem Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.